Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Caffeine
Drug ID BADD_D00332
Description Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to [Theophylline] and [Theobromine].[A187691,L9851] It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans.[T716] Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.[T716] The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999.[L9863] According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely.[A187694] Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.[T716]
Indications and Usage For management of fatigue, orthostatic hypotension, and for the short term treatment of apnea of prematurity in infants.
Marketing Status Not Available
ATC Code D11AX26; N06BC01
DrugBank ID DB00201
KEGG ID D00528
MeSH ID D002110
PubChem ID 2519
TTD Drug ID D0B3HD
NDC Product Code 41250-320; 21130-944; 65724-4012; 66715-5930; 55301-226; 63083-1508; 70677-0021; 76162-002; 49035-226; 58624-0306; 65724-4013; 38779-0419; 0363-5009; 56062-030; 53943-320; 41163-226; 11822-0691; 72036-020; 63941-020; 65724-4000; 51552-0200; 69842-509; 68016-680; 10267-5010; 66715-5830; 62959-955; 41520-708; 33992-2261; 0113-0409; 69842-500; 66715-5530; 50804-262; 46122-457; 58624-0308; 0363-0226; 58624-0310; 58624-0302; 66715-9799; 58624-0312; 36800-844; 0363-3440; 30142-726; 68210-4030; 11822-2260; 69168-076; 63868-114; 21130-226; 62959-954; 52389-155; 58624-0534; 49452-1320; 63940-229; 67091-117; 58624-0316; 72476-102; 57243-226; 37808-409; 52389-656; 62011-0340; 55319-226; 68998-076; 58624-0314; 70000-0154; 66715-5730; 58624-0304; 59779-345; 15579-201; 70000-0409; 55910-226; 46017-012; 52389-406; 65724-4004; 67751-160; 49483-343; 65724-4008; 56062-409; 41163-434
Synonyms Caffeine | 1,3,7-Trimethylxanthine | Vivarin | Caffedrine | Coffeinum N | Percutaféine | Dexitac | Durvitan | No Doz | Percoffedrinol N | Quick-Pep | Quick Pep | QuickPep | Coffeinum Purrum
Chemical Information
Molecular Formula C8H10N4O2
CAS Registry Number 58-08-2
SMILES CN1C=NC2=C1C(=O)N(C(=O)N2C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HepatotoxicityMetallothionein-1AP04731Not Available3823609; 3363219; 3704312
Metabolic acidosisAdenosine receptor A1Q60612Not Available25925253
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Retinopathy of prematurity18.04.01.004; 12.01.04.009; 06.09.01.004--Not Available
Rhabdomyolysis15.05.05.0020.000494%
Seizure17.12.03.0010.000329%
Sepsis11.01.11.003--
Skin disorder23.03.03.007--Not Available
Stroke volume increased13.14.02.004--Not Available
Suicide attempt19.12.01.0040.000494%
Supraventricular tachycardia02.03.03.0120.000329%
Tachycardia02.03.02.0070.000823%Not Available
Tachypnoea22.02.01.0140.000329%Not Available
Thyroxine decreased13.10.06.007--Not Available
Toxic encephalopathy12.03.01.027; 17.13.01.0040.000329%Not Available
Tremor17.01.06.0020.000494%
Unresponsive to stimuli17.02.05.0310.000329%Not Available
Ventricular extrasystoles02.03.04.0070.000329%Not Available
Ventricular fibrillation02.03.04.0080.000494%
Vomiting07.01.07.0030.001481%
Seasonal allergy22.04.04.008; 10.01.04.001; 06.04.01.0130.000658%Not Available
Necrotising colitis07.08.01.013--Not Available
Eye pruritus06.04.05.0060.000329%Not Available
Infusion site phlebitis24.05.03.002; 08.02.05.003; 12.07.05.004--Not Available
Necrotising enterocolitis neonatal18.04.11.002; 07.08.03.011--Not Available
Haemorrhage24.07.01.002--Not Available
Infusion site inflammation12.07.05.020; 08.02.05.020--Not Available
Urine output increased13.13.03.002--Not Available
Cardiac disorder02.01.01.003--Not Available
Infestation11.09.01.001; 23.09.05.001--Not Available
Malnutrition14.03.02.004--Not Available
Inner ear disorder04.04.02.002--Not Available
Psychotic disorder19.03.01.0020.000329%
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages